List of works by Magnus Gisslén

An example of genetically distinct HIV type 1 variants in cerebrospinal fluid and plasma during suppressive therapy.

scientific article published on 12 December 2013

Antiretroviral treatment for HIV infection: Swedish recommendations 2019

scientific article published on 11 January 2020

Antiretroviral treatment of human immunodeficiency virus infection: Swedish recommendations

scientific article

Approach to cerebrospinal fluid (CSF) biomarker discovery and evaluation in HIV infection

scientific article published on 13 August 2013

Bilirubin-a potential marker of drug exposure in atazanavir-based antiretroviral therapy

scientific article published on 13 September 2011

Central nervous system immune activation characterizes primary human immunodeficiency virus 1 infection even in participants with minimal cerebrospinal fluid viral burden

scientific article published in September 2011

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection

scientific article

Cerebrospinal fluid analysis for HIV replication and biomarkers of immune activation and neurodegeneration in long-term atazanavir/ritonavir monotherapy treated patients

scientific article published on July 2016

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

scientific article

Cognitive and neuronal link with inflammation: a longitudinal study in people with and without HIV infection

scientific article published on 11 September 2020

Contagiousness in treated HIV-1 infection

scientific article published on 12 October 2020

Defining and evaluating HIV-related neurodegenerative disease and its treatment targets: a combinatorial approach to use of cerebrospinal fluid molecular biomarkers

scientific article published on 12 September 2006

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis

scientific article published on 17 June 2019

Evaluating predictive markers for viral rebound and safety assessment in blood and lumbar fluid during HIV-1 treatment interruption

scientific article published on 13 February 2020

HIV-1 RNA is not detectable in the cerebrospinal fluid during antiretroviral combination therapy ⬇️

scientific article published on July 15, 1997

HIV-1 transmission between MSM and heterosexuals, and increasing proportions of circulating recombinant forms in the Nordic Countries

scientific article published on January 2016

Herpes zoster in HIV-1 infection: The role of CSF pleocytosis in secondary CSF escape and discordance

scientific article published on 22 July 2020

Kinetics of microbial translocation markers in patients on efavirenz or lopinavir/r based antiretroviral therapy

scientific article

Lopinavir/ritonavir, atazanavir/ritonavir, and efavirenz in antiretroviral-naïve HIV-1-infected individuals over 144 weeks: an open-label randomized controlled trial

scientific article published on 7 January 2013

Low levels of HIV-1 RNA detected in the cerebrospinal fluid after up to 10 years of suppressive therapy are associated with local immune activation

scientific article published in September 2014

Low prevalence of transmitted drug resistance in patients newly diagnosed with HIV-1 infection in Sweden 2003-2010

scientific article

Neurochemical evidence of astrocytic and neuronal injury commonly found in COVID-19

scientific article published on 16 June 2020

No evidence of neuronal damage as measured by neurofilament light chain in a HIV cure study utilising a kick-and-kill approach

scientific article published in 2021

Non-AIDS Mortality Is Higher Among Successfully Treated People Living with HIV Compared with Matched HIV-Negative Control Persons: A 15-Year Follow-Up Cohort Study in Sweden

article

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate

scientific article published on 11 December 2019

Potential for early antiretroviral therapy to reduce central nervous system HIV-1 persistence

scientific article published on 01 December 2019

Progressive increase in central nervous system immune activation in untreated primary HIV-1 infection

scientific article

Recent increased identification and transmission of HIV-1 unique recombinant forms in Sweden

scientific article

Risk of HIV transmission from patients on antiretroviral therapy: a position statement from the Public Health Agency of Sweden and the Swedish Reference Group for Antiviral Therapy

scientific article

Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders

scientific article published on 21 October 2020

Surveillance of wastewater revealed peaks of SARS-CoV-2 preceding those of hospitalized patients with COVID-19

scientific article published on 10 November 2020

Switching from a regimen containing abacavir/lamivudine or emtricitabine/tenofovir disoproxil fumarate to emtricitabine/tenofovir alafenamide fumarate does not affect central nervous system HIV-1 infection

scientific article published on 26 September 2019

Temporal trends in the Swedish HIV-1 epidemic: increase in non-B subtypes and recombinant forms over three decades

scientific article

Viral blips during suppressive antiretroviral treatment are associated with high baseline HIV-1 RNA levels

scientific article

Paulina is supported by:

About Paulina

Help